X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (39) 39
hematology (28) 28
von willebrand factor - genetics (21) 21
female (19) 19
index medicus (16) 16
male (16) 16
von willebrand diseases - genetics (15) 15
von willebrand factor (15) 15
peripheral vascular disease (11) 11
von willebrand disease (11) 11
adult (10) 10
mutation (9) 9
aged (8) 8
middle aged (8) 8
risk factors (8) 8
von willebrand factor - metabolism (8) 8
von willebrand diseases - blood (6) 6
von willebrand diseases - diagnosis (6) 6
vonwillebrand-factor (6) 6
alleles (5) 5
disease (5) 5
genotype (5) 5
identification (5) 5
medicine, general & internal (5) 5
pedigree (5) 5
research (5) 5
transfection (5) 5
venous thrombosis - genetics (5) 5
von willebrand diseases - classification (5) 5
von willebrand factor - analysis (5) 5
abridged index medicus (4) 4
adolescent (4) 4
analysis (4) 4
aspirin (4) 4
care and treatment (4) 4
case-control studies (4) 4
cell line (4) 4
deep-vein thrombosis (4) 4
drug resistance (4) 4
factor gene (4) 4
factor viii - genetics (4) 4
genes, dominant (4) 4
hemophilia-a (4) 4
heterozygote (4) 4
mutation, missense (4) 4
mutations (4) 4
myocardial-infarction (4) 4
phenotype (4) 4
platelet aggregation inhibitors - therapeutic use (4) 4
prevalence (4) 4
retrospective studies (4) 4
surgery (4) 4
thrombocytopenia (4) 4
thromboembolism (4) 4
thrombosis (4) 4
trauma (4) 4
von willebrand diseases - drug therapy (4) 4
von willebrand factor - chemistry (4) 4
von-willebrand-factor (4) 4
abo blood-group (3) 3
aged, 80 and over (3) 3
aspirin - therapeutic use (3) 3
bleeding (3) 3
blood coagulation (3) 3
blood coagulation, fibrinolysis and cellular haemostasis (3) 3
blood group (3) 3
blood platelets (3) 3
cardiovascular diseases - prevention & control (3) 3
child, preschool (3) 3
complications and side effects (3) 3
cysteine (3) 3
deamino arginine vasopressin - therapeutic use (3) 3
dimerization (3) 3
dna mutational analysis (3) 3
drug therapy (3) 3
exons (3) 3
factor viii (3) 3
factor viii - metabolism (3) 3
factor-v-leiden (3) 3
factor-viii (3) 3
family health (3) 3
genetics (3) 3
haplotypes (3) 3
hemorrhage (3) 3
hemorrhage - etiology (3) 3
inherited bleeding disorders (3) 3
medicine (3) 3
mortality (3) 3
netherlands (3) 3
point mutation (3) 3
polymorphism, single nucleotide (3) 3
pregnancy (3) 3
risk (3) 3
venous thrombosis (3) 3
venous thrombosis - blood (3) 3
von willebrand diseases - metabolism (3) 3
von willebrand factor - secretion (3) 3
von willebrand's disease (3) 3
activated protein-c (2) 2
alloantibodies (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


New England Journal of Medicine, ISSN 0028-4793, 02/2017, Volume 376, Issue 7, pp. 701 - 702
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2015, Volume 373, Issue 19, pp. 1882 - 1884
To the Editor: Recently, on the basis of an intermediate-probability 4T score and a positive anti–PF4–heparin particle-gel immunoassay, a patient in our... 
MEDICINE, GENERAL & INTERNAL | Female | Thrombocytopenia - chemically induced | Heparin - adverse effects | Antithrombins - therapeutic use | Humans | Pipecolic Acids - therapeutic use | Thrombocytopenia | Anticoagulants | Side effects | Immune response | Heparin | Thrombosis | Catheters
Journal Article
British Journal of Haematology, ISSN 0007-1048, 01/2019
textabstractIn daily haematological practice, predicting bleeding in thrombocytopenic patients is difficult, and clinicians adhere to transfusion triggers to... 
CRP | microalbuminuria | haemorrhage | thrombocytopenia | platelet transfusion
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2016, Volume 375, Issue 21, pp. 2067 - 2080
Von Willebrand's disease is the most common inherited bleeding disorder and is generally transmitted as an autosomal dominant trait. It is mainly associated... 
Von Willebrand's disease | Genetic disorders | Hematology | Mucosa | Surgery | Mutation | Blood diseases | Trauma | Bleeding
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2017, Volume 376, Issue 7, pp. 701 - 702
To the Editor: In their review article on von Willebrand’s disease, Leebeek and Eikenboom (Nov. 24 issue) 1 state that it is reasonable to measure both levels... 
Coagulation factors | Hemostasis | Surgery | Von Willebrand factor | Glycoproteins | Alloantibodies | Health risk assessment | Ristocetin
Journal Article
Thrombosis Research, ISSN 0049-3848, 12/2019, Volume 184, pp. 122 - 128
Home treatment of cancer-associated venous thromboembolism (VTE) is challenging due to the high risk of adverse events. While home treatment is quite agreeable... 
Anticoagulation | Outpatients | Medical oncology | Venous thromboembolism | Ambulatory care | DEEP-VEIN THROMBOSIS | HEPARIN | CARE | HOSPITALIZATION | ACUTE PULMONARY-EMBOLISM | INPATIENT TREATMENT | PERIPHERAL VASCULAR DISEASE | QUALITY-OF-LIFE | HEMATOLOGY | OUTPATIENT MANAGEMENT
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 1180 - 1180
Abstract Type I von Willebrand disease (VWD) is the most frequent bleeding disorder, with a prevalence of 10-50 cases per 10,000 persons. VWD usually shows an... 
Journal Article
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 2011, Volume 106, Issue 5, pp. 885 - 892
Journal Article
British Journal of Haematology, ISSN 0007-1048, 11/2010, Volume 151, Issue 3, pp. 245 - 251
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 2464 - 2464
Abstract Although rare, type 3 von Willebrand disease (VWD3) is of major interest because of its severe clinical presentation, the need for replacement therapy... 
Journal Article
Transfusion, ISSN 0041-1132, 09/2008, Volume 48, Issue 9, pp. 1959 - 1965
BACKGROUND: Despite supportive care with platelet (PLT) transfusions, bleeding complications occur in a substantial number of patients with thrombocytopenia... 
INCREMENTS | ONCOLOGY | TRANSFUSION | BONE-MARROW-TRANSPLANTATION | ENDOTHELIAL DAMAGE | MARKERS | CELL TRANSPLANTATION | THROMBOCYTOPENIA | COUNT | HEMATOLOGY | CANCER | Follow-Up Studies | Humans | Middle Aged | Hemorrhage - mortality | Male | Survival Rate | Treatment Outcome | Platelet Transfusion - adverse effects | Regression Analysis | Hemorrhage - etiology | Survival Analysis | Adult | Female | Bleeding Time
Journal Article
Transfusion, ISSN 0041-1132, 03/2009, Volume 49, Issue 3, pp. 570 - 577
BACKGROUND: Recombinant activated Factor VII (rFVIIa) is a prohemostatic agent used for treatment of hemophilia patients with inhibiting antibodies. It has... 
SURGERY | TRIAL | LIVER-TRANSPLANTATION | THERAPY | TRANSFUSION | BLOOD-LOSS | DOUBLE-BLIND | INTRACEREBRAL HEMORRHAGE | HEMATOLOGY | TRAUMA | RFVIIA | Humans | Middle Aged | Male | Survival Rate | Factor VIIa - therapeutic use | Blood Cell Count | Hemorrhage - drug therapy | Blood Transfusion | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Care and treatment | Analysis | Hemophilia
Journal Article
Journal Article